Abstract
Migraine is one of the most common recurrent types of headache and is the seventh cause of disability. This neurological disorder is characterized by having pain in head and other various symptoms such as nausea, emesis, photophobia, phonophobia, and sometimes visual sensory disorders. Magnesium (Mg) is a necessary ion for human body and has a crucial role in health and life maintenance. One of the main roles of Mg is to conserve neurons electric potential. Therefore, magnesium deficiency can cause neurological complications. Migraine is usually related to low amounts of Mg in serum and cerebrospinal fluid (CSF). Deficits in magnesium have significant role in the pathogenesis of migraine. Mg has been extensively used in migraine prophylaxis and treatment. This review summarizes the role of Mg in migraine pathogenesis and the potential utilizations of Mg in the prevention and treatment of migraine with the emphasis on transdermal magnesium delivery.
Similar content being viewed by others
References
Arnold M (2018) Headache classification committee of the International Headache Society (IHS) the international classification of headache disorders. Cephalalgia 38(1):1–211
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ (2016) Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388(10053):1545–1602
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41(7):646–657
Stovner LJ, Andree C (2010) Prevalence of headache in Europe: a review for the Eurolight project. J Headache Pain 11(4):289
Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of migraine: a disorder of sensory processing. Physiol Rev 97(2):553–622
Dolati S, Marofi F, Babaloo Z, Aghebati-Maleki L, Roshangar L, Ahmadi M, Rikhtegar R, Yousefi M (2018) Dysregulated network of miRNAs involved in the pathogenesis of multiple sclerosis. Biomed Pharmacother 104:280–290
de Boer I, van den Maagdenberg AM, Terwindt GM (2019) Advance in genetics of migraine. Curr Opin Neurol 32(3):413–421
Shuen AY, Wong BY, Wei C, Liu Z, Li M, Cole DE (2009) Genetic determinants of extracellular magnesium concentration: analysis of multiple candidate genes, and evidence for association with the estrogen receptor α (ESR1) locus. Clin Chim Acta 409(1-2):28–32
Society HCCotIH (2013) The international classification of headache disorders, (beta version). Cephalalgia 33(9):629–808
Ong JJY, De Felice M (2017) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics:1–17
Khairmode DV, Kapare PR, Jadhav KL, Khade RH, Keskar CH, Ghongade KD, Kamble R, Mali AS (2018) Migraine is not just a headache. Pharma Sci Monit 9(1)
Giffin N, Lipton R, Silberstein S, Tvedskov J, Olesen J, Goadsby P (2005) The migraine postdrome: an electronic diary study. Cephalalgia 25(10):958
Louter M, Wardenaar K, Veen G, van Oosterhout W, Zitman F, Ferrari M, Terwindt G (2014) Allodynia is associated with a higher prevalence of depression in migraine patients. Cephalalgia 34(14):1187–1192
Cozzolino O, Marchese M, Trovato F, Pracucci E, Ratto GM, Buzzi MG, Sicca F, Santorelli FM (2018) Understanding spreading depression from headache to sudden unexpected death. Front Neurol 9:19
Mauskop A, Varughese J (2012) Why all migraine patients should be treated with magnesium. J Neural Transm 119(5):575–579
Agarwal R, Agarwal P (2014) Pathogenetic role of magnesium deficiency in ophthalmic diseases. Biometals 27(1):5–18
Sparaco M, Feleppa M, Lipton R, Rapoport A, Bigal M (2006) Mitochondrial dysfunction and migraine: evidence and hypotheses. Cephalalgia 26(4):361–372
Burstein R, Noseda R, Borsook D (2015) Migraine: multiple processes, complex pathophysiology. J Neurosci 35(17):6619–6629
Liebman TN, Crystal SC (2016) What is the evidence that riboflavin can be used for migraine prophylaxis? Einstein J Biol Med 27(1):7–9
Cevoli S, Favoni V, Cortelli P (2019) Energy metabolism impairment in migraine. Curr Med Chem
Chhater S, Karal R, Kumar B (2018) Review on migraine: pathophysiology and treatment. Am J Biomed Res 6(1):20–24
Malhotra R (2016) Understanding migraine: potential role of neurogenic inflammation. Ann Indian Acad Neurol 19(2):175–182
Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 6(10):573–582
Hoffmann J, Charles A (2018) Glutamate and its receptors as therapeutic targets for migraine. Neurotherapeutics 15(2):361–370
Aggarwal M, Puri V, Puri S (2012) Serotonin and CGRP in migraine. Ann Neurosci 19(2):88–94
Kojić Z, Stojanović D (2013) Pathophysiology of migraine: from molecular to personalized medicine. Med Pregl 66(1-2):53–57
Hoffmann J (2011) Recent advances in headache research. Expert Rev Neurother 11(10):1379–1381
Coppola G, Schoenen J (2012) Cortical excitability in chronic migraine. Curr Pain Headache Rep 16(1):93–100
Karsan N, Goadsby PJ (2018) Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol:1
Charbit AR, Akerman S, Goadsby PJ (2011) Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. PAIN® 152(10):2365–2376
Chen Z, Chen X, Liu M, Dong Z, Ma L, Yu S (2017) Altered functional connectivity of amygdala underlying the neuromechanism of migraine pathogenesis. J Headache Pain 18(1):7
Ong JJY, De Felice M (2018) Migraine treatment: current acute medications and their potential mechanisms of action. Neurotherapeutics 15(2):274–290
Taylor FR (2011) Nutraceuticals and headache: the biological basis. Headache 51(3):484–501
De Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95(1):1–46
Romani AM (2013) Magnesium in health and disease. Interrelations between essential metal ions and human diseases. Springer, In, pp 49–79
Teigen L, Boes CJ (2015) An evidence-based review of oral magnesium supplementation in the preventive treatment of migraine. Cephalalgia 35(10):912–922
Sun-Edelstein C, Mauskop A (2009) Role of magnesium in the pathogenesis and treatment of migraine. Expert Rev Neurother 9(3):369–379
Pizza V, Milano W, Padricelli U, Capasso A (2017) NOVEL THERAPEUTIC INVESTIGATIONS IN MIGRAINE PAIN
Nattagh-Eshtivani E, Sani MA, Dahri M, Ghalichi F, Ghavami A, Arjang P, Tarighat-Esfanjani A (2018) The role of nutrients in the pathogenesis and treatment of migraine headaches. Biomed Pharmacother 102:317–325
Kirkland AE, Sarlo GL, Holton KF (2018) The Role of Magnesium in Neurological Disorders. Nutrients 10(6)
Bianchi A, Salomone S, Caraci F, Pizza V, Bernardini R, D’Amato CC (2004) Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis.
Hoffmann J, Charles A (2018) Glutamate and its receptors as therapeutic targets for migraine. Neurotherapeutics:1–10
Shindo Y, Fujimoto A, Hotta K, Suzuki K, Oka K (2010) Glutamate-induced calcium increase mediates magnesium release from mitochondria in rat hippocampal neurons. J Neurosci Res 88(14):3125–3132
Rybicka M, Baranowska-Bosiacka I, Zyluk B, Nowacki P, Chlubek D (2012) The role of magnesium in migraine pathogenesis. Potential use of magnesium compounds in prevention and treatment of migraine headaches. J Elementol 17(2)
Stuart S, Griffiths LR (2012) A possible role for mitochondrial dysfunction in migraine. Mol Gen Genomics 287(11-12):837–844
Daniel O, Mauskop A (2016) Nutraceuticals in acute and prophylactic treatment of migraine. Curr Treat Options Neurol 18(4):14
Izzati-Zade K (2008) The role of serotonin in the pathogenesis and clinical presentations of migraine attacks. Neurosci Behav Physiol 38(5):501–505
Dussor G (2014) Serotonin, 5HT1 agonists, and migraine: new data, but old questions still not answered. Curr Opin Support Palliat Care 8(2):137
Holland S, Silberstein S, Freitag F, Dodick D, Argoff C, Ashman E (2012) Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults:[RETIRED]: report of the quality standards subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78(17):1346–1353
Dolati S, Ahmadi M, Rikhtegar R, Babaloo Z, Ayromlou H, Aghebati-Maleki L, Nouri M, Yousefi M (2018) Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis. Int Immunopharmacol 61:74–81
Nowak L, Bregestovski P, Ascher P, Herbet A, Prochiantz A (1984) Magnesium gates glutamate-activated channels in mouse central neurones. Nature 307(5950):462
Seçil Y, Ünde C, Beckmann YY, Bozkaya YT, Özerkan F, Başoğlu M (2010) Blood pressure changes in migraine patients before, during and after migraine attacks. Pain Pract 10(3):222–227
Olesen J (2008) The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther 120(2):157–171
Yorns WR Jr, Hardison HH (2013) Mitochondrial dysfunction in migraine. Semin Pediatr Neurol 3. Elsevier:188–193
Ong JJY, Wei DY-T, Goadsby PJ (2018) Recent advances in pharmacotherapy for migraine prevention: from pathophysiology to new drugs. Drugs 78(4):411–437
Von Luckner A, Riederer F (2018) Magnesium in migraine prophylaxis—is there an evidence-based rationale? A systematic review. Headache 58(2):199–209
DeMaagd G (2008) The pharmacological management of migraine, part 2: preventative therapy. Pharm Ther 33(8):480
Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB (2007) Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention Study: CME. Headache 47(3):355–363
Armstrong C (2013) AAN/AHS update recommendations for migraine prevention in adults. Am Fam Physician 87(8):584–585
Chruścikowska AJJOPH, NURSING, RESCUE M (2015) Migraine prophylaxis in pregnancy–the effects of magnesium. 142 (2015_2):07-10
Lodi R, Iotti S, Cortelli P, Pierangeli G, Cevoli S, Clementi V, Soriani S, Montagna P, Barbiroli B (2001) Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Res Bull 54(4):437–441
Pringsheim T, Davenport WJ, Becker WJ (2010) Prophylaxis of migraine headache. Can Med Assoc J 182(7):E269–E276
Wang F, Van Den Eeden SK, Ackerson LM, Salk SE, Reince RH, Elin RJ (2003) Oral magnesium oxide prophylaxis of frequent migrainous headache in children: a randomized, double-blind, placebo-controlled trial. Headache 43(6):601–610
Kelley NE, Tepper DE (2012) Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium. Headache 52(1):114–128
Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G (1991) Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 31(5):298–301
Peikert A, Wilimzig C, Köhne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 16(4):257–263
Esfanjani AT, Mahdavi R, Mameghani ME, Talebi M, Nikniaz Z, Safaiyan A (2012) The effects of magnesium, l-carnitine, and concurrent magnesium–l-carnitine supplementation in migraine prophylaxis. Biol Trace Elem Res 150(1-3):42–48
Gaul C, Diener H-C, Danesch U, Group MS (2015) Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial. J Headache Pain 16(1):32
Giorgio Dalla V, Zavarize P, Ngonga G, Pezzini A, Dalla Volta G (2017) Combination of tanacethum partenium, 5-hydrossitriptophan (5-Http) and magnesium in the prophylaxis of episodic migraine without aura (AURASTOP®) an observational study. Int J Neurol Brain Disord 4(1):0-0
Giorgio Dalla V, Antonaci F, Rebecchi V, Sances G, Merlo P, Giorgetti A, Di Palma F, Matta E, Dallocchio C, Tassorelli C (2018) AURASTOP ® in the treatment of migraine aura. Int J Neurol Brain Disord 5(1):11–14
Mainardi F, Merlo P, Maggioni F, Zanchin G, Dalla Volta G (2018) Efficacy of a combination of tanacetum parthenium, 5-hydroxy tryptophan and magnesium (Aurastop) in episodic migraine prevention: a multicentric observational study. Open Access Library J 5(08):1
Guilbot A, Bangratz M, Abdellah SA, Lucas C (2017) A combination of coenzyme Q10, feverfew and magnesium for migraine prophylaxis: a prospective observational study. BMC Complement Altern Med 17(1):433
Karimi N, Razian A, Heidari M (2019) The efficacy of magnesium oxide and sodium valproate in prevention of migraine headache: a randomized, controlled, double-blind, crossover study. Acta Neurol Belg:1–7
Mauskop A, Altura BT, Cracco RQ, Altura BM (1996) Intravenous magnesium sulfate rapidly alleviates headaches of various types. Headache 36(3):154–160
Demirkaya Ş, Vural O, Dora B, Topçuoğlu MA (2001) Efficacy of intravenous magnesium sulfate in the treatment of acute migraine attacks. Headache 41(2):171–177
Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ (2001) Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med 38(6):621–627
Bigal M, Bordini C, Tepper S, Speciali J (2002) Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia 22(5):345–353
Frank LR, Olson CM, Shuler KB, Gharib SF (2004) Intravenous magnesium for acute benign headache in the emergency department: a randomized double-blind placebo-controlled trial. Can J Emerg Med 6(5):327–332
Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C (2005) A randomized prospective placebo-controlled study of intravenous magnesium sulphate vs. metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia 25(3):199–204
Choi H, Parmar N (2014) The use of intravenous magnesium sulphate for acute migraine: meta-analysis of randomized controlled trials. Eur J Emerg Med 21(1):2–9
Kasmaei HD, Amiri M, Negida A, Hajimollarabi S, Mahdavi N (2017) Ketorolac versus magnesium sulfate in migraine headache pain management; a preliminary study. Emergency 5(1)
Baratloo A, Mirbaha S, Delavar Kasmaei H, Payandemehr P, Elmaraezy A, Negida A (2017) Intravenous caffeine citrate vs. magnesium sulfate for reducing pain in patients with acute migraine headache; a prospective quasi-experimental study. Korean J Pain 30(3):176–182
Ha H, Gonzalez A (2019) Migraine headache prophylaxis. Am Fam Physician 99(1)
Sprenger T, Viana M, Tassorelli C (2018) Current prophylactic medications for migraine and their potential mechanisms of action. Neurotherapeutics:1–11
Chiu H-Y, Yeh TH, Huang YC, Chen PY (2016) Effects of intravenous and oral magnesium on reducing migraine: a meta-analysis of randomized controlled trials. Pain Phys 19(1):E97–E112
Pagliaro MJ, Pagliaro MM (2014) Method and device or pharmaceutical compositions for the transdermal delivery of magnesium directly to the neuromuscular junction for the treatment of muscle cramping. Google Patents
Gröber U, Werner T, Vormann J, Kisters K (2017) Myth or reality—transdermal magnesium? Nutrients 9(8):813
Shealy N (2000) Holy Water, Sacred oil: the fountain of youth. Biogenics Books, New York
Sircus M (2011) Transdermal magnesium therapy: a new modality for the maintenance of health. iUniverse,
Jepps OG, Dancik Y, Anissimov YG, Roberts MS (2013) Modeling the human skin barrier—Towards a better understanding of dermal absorption. Adv Drug Deliv Rev 65(2):152–168
Bourke B (2008) Magnesium chloride for health and rejuvenation.
Reddy B Achieving optimal health through transdermal magnesium therapy
Chandrasekaran NC, Sanchez WY, Mohammed YH, Grice JE, Roberts MS, Barnard RT (2016) Permeation of topically applied Magnesium ions through human skin is facilitated by hair follicles. Magnes Res 29(2):35–42
Watkins K, Josling P (2010) A pilot study to determine the impact of transdermal magnesium treatment on serum levels and whole body CaMg ratios. Nutr Pract 14:1–7
Acknowledgments
We would also like to show our gratitude to the Aging Research Institute, Tabriz University of Medical Sciences for supporting this work.
Author information
Authors and Affiliations
Contributions
Sanam Dolati wrote the manuscript and edited the final version of the manuscript. Reza Rikhtegar designed and wrote manuscript. Amir Mehdizadeh drew the table and submitted the paper. Mehdi Yousefi supervised the study and correspondence during the paper submission.
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Dolati, S., Rikhtegar, R., Mehdizadeh, A. et al. The Role of Magnesium in Pathophysiology and Migraine Treatment. Biol Trace Elem Res 196, 375–383 (2020). https://doi.org/10.1007/s12011-019-01931-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-019-01931-z